- Home
- BTCM vs KLRS Comparison
BTCM vs KLRS Comparison
Compare BTCM & KLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTCM
- KLRS
- Stock Information
- Founded
- BTCM 2001
- KLRS 2019
- Country
- BTCM United States
- KLRS United States
- Employees
- BTCM N/A
- KLRS N/A
- Industry
- BTCM EDP Services
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BTCM Technology
- KLRS Health Care
- Exchange
- BTCM Nasdaq
- KLRS Nasdaq
- Market Cap
- BTCM 47.8M
- KLRS 46.0M
- IPO Year
- BTCM 2013
- KLRS N/A
- Fundamental
- Price
- BTCM $2.77
- KLRS $4.08
- Analyst Decision
- BTCM Hold
- KLRS Buy
- Analyst Count
- BTCM 1
- KLRS 1
- Target Price
- BTCM N/A
- KLRS N/A
- AVG Volume (30 Days)
- BTCM 501.5K
- KLRS 82.7K
- Earning Date
- BTCM 08-14-2025
- KLRS 08-13-2025
- Dividend Yield
- BTCM N/A
- KLRS N/A
- EPS Growth
- BTCM N/A
- KLRS N/A
- EPS
- BTCM N/A
- KLRS N/A
- Revenue
- BTCM $24,576,000.00
- KLRS N/A
- Revenue This Year
- BTCM $14.32
- KLRS N/A
- Revenue Next Year
- BTCM N/A
- KLRS N/A
- P/E Ratio
- BTCM N/A
- KLRS N/A
- Revenue Growth
- BTCM N/A
- KLRS N/A
- 52 Week Low
- BTCM $1.22
- KLRS $2.14
- 52 Week High
- BTCM $8.07
- KLRS $24.15
- Technical
- Relative Strength Index (RSI)
- BTCM 46.05
- KLRS 81.23
- Support Level
- BTCM $2.76
- KLRS $2.37
- Resistance Level
- BTCM $3.18
- KLRS $2.58
- Average True Range (ATR)
- BTCM 0.30
- KLRS 0.29
- MACD
- BTCM -0.03
- KLRS 0.16
- Stochastic Oscillator
- BTCM 10.26
- KLRS 97.24
About BTCM BIT Mining Limited ADS
BIT Mining Ltd is a cryptocurrency mining company, with a long-term plan to encompass the whole cryptocurrency value chain. Its business covers cryptocurrency mining, mining pool, data center operation and mining machine manufacturing. The company has a related and growing deployed Bitcoin mining machine capacity, owns three hydroelectric cryptocurrency mines with combined power capacity of 435MW and the entire mining pool business operated under BTC.com, including the domain name and wallet. It has also entered into a definitive agreement to acquire a 7 nanometer cryptocurrency mining machine manufacturer "Bee Computing", completing its vertical integration, making self-sufficient while also strengthening competitive position.
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.